Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey.

Gruffydd-Jones K, Thomas M, Roman-Rodríguez M, Infantino A, FitzGerald JM, Pavord I, Haddon JM, Elsasser U, Vogelberg C.

J Asthma Allergy. 2019 Jul 11;12:183-194. doi: 10.2147/JAA.S204278. eCollection 2019.

2.

Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019.

Gruffydd-Jones K, Keeley D, Knowles V, Recabarren X, Woodward A, Sullivan AL, Loebinger MR, Payne K, Harvey A, Grillo L, Welham SA, Hill AT.

NPJ Prim Care Respir Med. 2019 Jun 27;29(1):24. doi: 10.1038/s41533-019-0136-8. Review.

3.

Unmet needs in asthma.

Gruffydd-Jones K.

Ther Clin Risk Manag. 2019 Mar 14;15:409-421. doi: 10.2147/TCRM.S160327. eCollection 2019. Review.

4.

British Thoracic Society guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

BMJ Open Respir Res. 2018 Dec 28;5(1):e000348. doi: 10.1136/bmjresp-2018-000348. eCollection 2018.

5.

British Thoracic Society Guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher PW, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463. No abstract available.

PMID:
30545985
6.

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.

Price DB, Buhl R, Chan A, Freeman D, Gardener E, Godley C, Gruffydd-Jones K, McGarvey L, Ohta K, Ryan D, Syk J, Tan NC, Tan T, Thomas M, Yang S, Konduru PR, Ngantcha M, d'Alcontres MS, Lapperre TS.

Lancet Respir Med. 2018 Jan;6(1):29-39. doi: 10.1016/S2213-2600(17)30424-1. Epub 2017 Nov 3.

PMID:
29108938
7.

Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation.

Wan Yau Ming S, Haughney J, Small I, Wolfe S, Hamill J, Gruffydd-Jones K, Daly C, Soriano JB, Gardener E, Skinner D, Stagno d'Alcontres M, Price DB.

Respir Med. 2017 Aug;129:199-206. doi: 10.1016/j.rmed.2017.06.016. Epub 2017 Jun 24.

8.

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study.

Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D.

NPJ Prim Care Respir Med. 2017 Jun 8;27:17004. doi: 10.1038/npjpcrm.2017.4.

9.

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9.

PMID:
28286157
10.

Managing multimorbidity in primary care in patients with chronic respiratory conditions.

Morrison D, Agur K, Mercer S, Eiras A, González-Montalvo JI, Gruffydd-Jones K.

NPJ Prim Care Respir Med. 2016 Sep 15;26:16043. doi: 10.1038/npjpcrm.2016.43.

11.

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational.

Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D.

NPJ Prim Care Respir Med. 2016 Feb 25;26:16002. doi: 10.1038/npjpcrm.2016.2. Erratum in: NPJ Prim Care Respir Med. 2017 Jun 8;27:17004.

12.

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.

13.

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Brusselle G, Price D, Gruffydd-Jones K, Miravitlles M, Keininger DL, Stewart R, Baldwin M, Jones RC.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 15;10:2207-17. doi: 10.2147/COPD.S91694. eCollection 2015.

14.

Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.

McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.

Respir Med. 2015 Feb;109(2):228-37. doi: 10.1016/j.rmed.2014.12.006. Epub 2014 Dec 30.

15.

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:889-904. doi: 10.2147/COPD.S62750. eCollection 2014.

16.

A woman with breathlessness: a practical approach to diagnosis and management.

Kaplan A, Gruffydd-Jones K, van Gemert F, Kirenga BJ, Medford AR.

Prim Care Respir J. 2013 Dec;22(4):468-76. doi: 10.4104/pcrj.2013.00100.

17.

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care.

Price D, Ryan D, Burden A, Von Ziegenweidt J, Gould S, Freeman D, Gruffydd-Jones K, Copland A, Godley C, Chisholm A, Thomas M.

Clin Transl Allergy. 2013 Nov 7;3(1):37. doi: 10.1186/2045-7022-3-37.

18.

Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients.

Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, Harris T, Burden A, Brockman J, King C, Papi A.

Prim Care Respir J. 2013 Dec;22(4):439-48. doi: 10.4104/pcrj.2013.00088.

19.

The distribution of COPD in UK general practice using the new GOLD classification.

Haughney J, Gruffydd-Jones K, Roberts J, Lee AJ, Hardwell A, McGarvey L.

Eur Respir J. 2014 Apr;43(4):993-1002. doi: 10.1183/09031936.00065013. Epub 2013 Oct 31.

20.

The Primary Care Respiratory Society-UK Quality Award: development and piloting of quality standards for primary care respiratory medicine.

Gruffydd-Jones K, Small I, Fletcher M, Bryant T.

Prim Care Respir J. 2013 Sep;22(3):353-9. doi: 10.4104/pcrj.2013.00065.

21.

The prevalence of PFS and prevalence and characteristics of reported food allergy; a survey of UK adults aged 18-75 incorporating a validated PFS diagnostic questionnaire.

Skypala IJ, Bull S, Deegan K, Gruffydd-Jones K, Holmes S, Small I, Emery PW, Durham SR.

Clin Exp Allergy. 2013 Aug;43(8):928-40. doi: 10.1111/cea.12104.

PMID:
23889246
22.

Novel study design to assess the utility of the copd assessment test in a primary care setting.

Gruffydd-Jones K, Marsden H, Holmes S, Kardos P, Escamilla R, Dal Negro R, Roberts J, Nadeau G, Leather D, Jones P.

BMC Med Res Methodol. 2013 May 10;13:63. doi: 10.1186/1471-2288-13-63.

23.

Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial.

Gruffydd-Jones K, Marsden HC, Holmes S, Kardos P, Escamilla R, Dal Negro R, Roberts J, Nadeau G, Vasselle M, Leather DA, Jones P.

Prim Care Respir J. 2013 Mar;22(1):37-43. doi: 10.4104/pcrj.2013.00001.

24.

Activity levels after pulmonary rehabilitation - what really happens?

Dyer CA, Harris ND, Jenkin E, Langley-Johnson C, Lewis R, Taylor GJ, Gruffydd-Jones K.

Physiotherapy. 2013 Sep;99(3):228-32. doi: 10.1016/j.physio.2012.01.004. Epub 2012 Jul 9.

PMID:
23219642
25.

GOLD guidelines 2011: what are the implications for primary care?

Gruffydd-Jones K.

Prim Care Respir J. 2012 Dec;21(4):437-41. doi: 10.4104/pcrj.2012.00058.

26.

Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study.

Pinnock H, Burton C, Campbell S, Gruffydd-Jones K, Hannon K, Hoskins G, Lester H, Price D.

Prim Care Respir J. 2012 Sep;21(3):288-94. doi: 10.4104/pcrj.2012.00052.

27.

Conflicting standards for diagnostic spirometry within-session repeatability are confusing.

Gruffydd-Jones K, Pinnock H, Loveridge C, Wolfe S, McArthur R, Bellamy D.

Prim Care Respir J. 2012 Jun;21(2):136. doi: 10.4104/pcrj.2012.00044. No abstract available.

28.

The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?

Gruffydd-Jones K, Loveridge C.

Prim Care Respir J. 2011 Jun;20(2):199-204. doi: 10.4104/pcrj.2011.00011.

29.

NICE guidelines for chronic obstructive pulmonary disease: implications for primary care.

Gruffydd-Jones K, Jones MM.

Br J Gen Pract. 2011 Feb;61(583):91-2. doi: 10.3399/bjgp11X556182. No abstract available.

30.

Summary of the consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England.

Jones R, Gruffydd-Jones K, Pinnock H, Peffers SJ, Lawrence J, Scullion J, White P, Holmes S.

Prim Care Respir J. 2010 Dec;19 Suppl 2:S1-S17. doi: 10.4104/pcrj.2010.00081. Erratum in: Prim Care Respir J. 2011 Mar;20(1):32.

31.

Implementing the change in National Institute for Health and Clinical Excellence guidance on airflow obstruction grading in chronic obstructive pulmonary disease.

Jones RC, Gruffydd-Jones K, Price DB.

Thorax. 2011 Jun;66(6):543-4. doi: 10.1136/thx.2010.148510. Epub 2010 Oct 14. No abstract available.

PMID:
20947897
32.

A pilot study of identification and case management of high-risk COPD patients in a general practice.

Gruffydd-Jones K, Richman J, Jones RC, Wang X.

Fam Pract. 2010 Oct;27(5):494-8. doi: 10.1093/fampra/cmq045. Epub 2010 Jul 14.

PMID:
20631057
33.

Asthma Control Questionnaire in children: validation, measurement properties, interpretation.

Juniper EF, Gruffydd-Jones K, Ward S, Svensson K.

Eur Respir J. 2010 Dec;36(6):1410-6. doi: 10.1183/09031936.00117509. Epub 2010 Jun 7.

34.
35.

Assessing asthma control in routine clinical practice: use of the Royal College of Physicians '3 questions'.

Thomas M, Gruffydd-Jones K, Stonham C, Ward S, Macfarlane TV.

Prim Care Respir J. 2009 Jun;18(2):83-8. doi: 10.3132/pcrj.2008.00045.

36.

The use of exhaled nitric oxide monitoring in primary care asthma clinics: a pilot study.

Gruffydd-Jones K, Ward S, Stonham C, Macfarlane TV, Thomas M.

Prim Care Respir J. 2007 Dec;16(6):349-56.

37.

What are the needs of patients following discharge from hospital after an acute exacerbation of chronic obstructive pulmonary disease (COPD)?

Gruffydd-Jones K, Langley-Johnson C, Dyer C, Badlan K, Ward S.

Prim Care Respir J. 2007 Dec;16(6):363-8.

38.

Systematic review and meta-analysis of budesonide/formoterol in a single inhaler.

Edwards SJ, Gruffydd-Jones K, Ryan DP.

Curr Med Res Opin. 2007 Aug;23(8):1809-20. Review.

PMID:
17597557
39.

What standards and terms of employment should respiratory practitioners with a special interest expect from an employing organisation?

Gruffydd-Jones K, Stephenson P, Levy ML; GPIAG Working Party.

Prim Care Respir J. 2007 Jun;16(3):182-7.

40.

Can asthma control be improved by understanding the patient's perspective?

Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, Haughney J, Henrichsen SH, Kaplan A, Langhammer A, Østrem A, Thomas M, van der Molen T, Virchow JC, Williams S.

BMC Pulm Med. 2007 May 22;7:8. Review.

41.

A proposal for the annual appraisal of, and developmental support for, General Practitioners with a Specialist Interest (GPwSIs) in respiratory medicine.

Holmes S, Gruffydd-Jones K; General Practice Airways Group Education Sub-Committee.

Prim Care Respir J. 2005 Jun;14(3):161-5. Epub 2005 Mar 31.

42.

A proposal for the process of accreditation by portfolio for a GPwSI in respiratory medicine.

Gruffydd-Jones K; General Practice Airways Group; British Thoracic Society; Primary Care Group Royal College of Physicians; Royal College of Nursing; National Respiratory Training Centre; Respiratory Education and Training Centres.

Prim Care Respir J. 2005 Feb;14(1):13-20. Epub 2004 Dec 21. No abstract available.

43.
44.

Targeted routine asthma care in general practice using telephone triage.

Gruffydd-Jones K, Hollinghurst S, Ward S, Taylor G.

Br J Gen Pract. 2005 Dec;55(521):918-23.

45.

Clinical and economic issues associated with switching between triptans in clinical practice.

Dowson AJ, Fuat A, Gruffydd-Jones K.

Curr Med Res Opin. 2005 Mar;21(3):375-9.

PMID:
15811206
46.

Measuring pulmonary function in practice.

Gruffydd-Jones K.

Practitioner. 2002 Jun;246(1635):445-9. Review. No abstract available.

PMID:
12073703
47.

Effective treatments for migraine.

Gruffydd-Jones K.

Practitioner. 1997 Sep;241(1578):501-4, 506, 508-9. Review. No abstract available.

PMID:
9926580
48.

Improving child asthma care.

Collyer L, Gupta K, Gruffydd-Jones K, Pearce L.

Community Nurse. 1997 Jul;3(6):10-1. No abstract available.

PMID:
9469042
49.

Quality-of-life measures in asthma--do they matter to the GP?

Gruffydd-Jones K.

Br J Gen Pract. 1997 Jun;47(419):392-4.

50.

Supplemental Content

Loading ...
Support Center